News | July 06, 2009

AngioDynamics Rolls Out New RFA Device for Cancer Tumor Ablation

StarBurst XLi-Enhanced Semi-Flex

July 6, 2009 - The new StarBurst XLi-Enhanced Semi-Flex probe from AngioDynamics is a radiofrequency ablation (RFA) device specifically designed to deliver a 7-cm ablation of a tumor in a single placement during computed tomography-aided procedures.

The StarBurst series of devices deploy radiofrequency electrode tines – from the end a long wand inserted into the body percutaneously – to raise the temperature of cells above 45-50 degrees celsius and cause cellular death. Used by surgical oncologists, hepatobiliary surgeons, liver transplant surgeons, laparoscopists and interventional radiologists, these systems offer patients with unresectable liver lesions an effective treatment option with few side effects or complications.

Physicians can now call upon a single device with both the ablation capability of the StarBurst XLi-Enhanced probe, and the flexibility of the Semi-Flex device and its ability to maneuver around a CT gantry. The StarBurst XLi-Enhanced Semi-Flex is said to reduce the time required to perform procedures and can enable patients to resume normal activity within days.

“AngioDynamics’ radiofrequency devices have the lowest local tumor recurrence following treatment of all three RFA devices on the US market,” said Jan Keltjens, AngioDynamics CEO. “This new tool continues to build on our market leadership.”

The scalable design can create ablations from 4-7 cm, allowing physicians procedural flexibility. The device also gives dynamic, real-time temperature readouts and needle track ablation. The design provides superior ergonomics and clinician controls. An infusion-based system increases conductivity of the ablation zone, and an integrated tubing set allows for easy set up.

The new device is versatile with both rigid metal and flexible polymer trocar sections. Its ability to bend up to 90 degrees in all directions enables easy gantry entrance for CT systems. It can be used for percutaneous, laparoscopic and intraoperative procedures.

For more information: